Farmaceutica R (RO:RMAH) — Market Cap & Net Worth
Market Cap & Net Worth: Farmaceutica R (RMAH)
Farmaceutica R (RO:RMAH) has a market capitalization of $18.56 Million (RON80.84 Million) as of July 14, 2026. Listed on the RO stock exchange, this Romania-based company holds position #25356 globally and #53 in its home market, demonstrating a 2.89% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Farmaceutica R's stock price RON0.85 by its total outstanding shares 94658195 (94.66 Million). Review Farmaceutica R total liabilities to assess the company's total debt and financial obligations.
Farmaceutica R Market Cap History: 2015 to 2026
Farmaceutica R's market capitalization history from 2015 to 2026. Data shows growth from $2.63 Million to $18.56 Million (18.23% CAGR).
Index Memberships
Farmaceutica R is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Bucharest Plus Index
BETPLUS
|
$66.39 Billion | 0.03% | #34 of 42 |
|
Bucharest BET-XT Index
BETXT
|
$65.49 Billion | 0.03% | #22 of 28 |
Weight: Farmaceutica R's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Farmaceutica R Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Farmaceutica R's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Farmaceutica R's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.99x
Farmaceutica R's market cap is 1.99 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $9.56 Million | $441.48 Million | $37.77 Million | 0.02x | 0.25x |
| 2021 | $12.28 Million | $477.10 Million | $7.23 Million | 0.03x | 1.70x |
| 2022 | $11.16 Million | $535.85 Million | $5.81 Million | 0.02x | 1.92x |
| 2023 | $13.75 Million | $593.36 Million | $7.20 Million | 0.02x | 1.91x |
| 2024 | $14.35 Million | $743.79 Million | $6.96 Million | 0.02x | 2.06x |
| 2025 | $17.39 Million | $759.76 Million | $8.72 Million | 0.02x | 1.99x |
Competitor Companies of RMAH by Market Capitalization
Companies near Farmaceutica R in the global market cap rankings as of July 14, 2026.
Key companies related to Farmaceutica R by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #267 globally with a market cap of $94.62 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #533 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #636 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1109 globally with a market cap of $23.85 Billion USD ( AU$33.71 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #267 | McKesson Corporation | NYSE:MCK | $94.62 Billion | $812.28 |
| #533 | Cencora Inc. | NYSE:COR | $50.53 Billion | $306.13 |
| #636 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $233.66 |
| #1109 | Sigma Healthcare Ltd | AU:SIG | $23.85 Billion | AU$2.92 |
Farmaceutica R Historical Marketcap From 2015 to 2026
Between 2015 and today, Farmaceutica R's market cap moved from $2.63 Million to $ 18.56 Million, with a yearly change of 18.23%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RON18.56 Million | +6.75% |
| 2025 | RON17.39 Million | +21.21% |
| 2024 | RON14.35 Million | +4.30% |
| 2023 | RON13.75 Million | +23.21% |
| 2022 | RON11.16 Million | -9.07% |
| 2021 | RON12.28 Million | +28.39% |
| 2020 | RON9.56 Million | +83.83% |
| 2019 | RON5.20 Million | -9.56% |
| 2018 | RON5.75 Million | +25.05% |
| 2017 | RON4.60 Million | +91.15% |
| 2016 | RON2.41 Million | -8.44% |
| 2015 | RON2.63 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 14th, 2026 the market cap of Farmaceutica R was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.56 Million USD |
| MoneyControl | $18.56 Million USD |
| MarketWatch | $18.56 Million USD |
| marketcap.company | $18.56 Million USD |
| Reuters | $18.56 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Farmaceutica R
Farmaceutica REMEDIA S.A. operates a chain of pharmacies in Romania. It is also involved in the wholesale distribution of medicines to pharmacies, and public and private hospitals and clinics. In addition, the company provides packaging materials; and logistics and warehousing, promotion and marketing of drugs, and pharmaceutical products registration services. The company was incorporated in 199… Read more